Solventum

Health Care Health Care Technology Saint Paul, Minnesota Last filing Feb 27, 2026 · FY2025

                    Revenue
                    FY2025
                
$8.3B
                    3y CAGR +0.8%
                    
                    P20
                    
                    n/a
                    
                    Net income
                    FY2025
                
$1.6B
                    Net margin +18.7%
                    
                    P75
                    
                    n/a
                    
                    Total assets
                    FY2025
                
$14.3B
                    ROA +10.9%
                    
                    P73
                    
                    n/a
                    
                    Operating cash flow
                    FY2025
                
$369.0M
                    FCF margin -0.1%
                    
                    P6
                    
                    n/a

4 yrs · FY2022–FY2025 9 filed · 0 derived · 0 blank

1Y 3Y 5Y

Dollars % of revenue % of assets YoY % CAGR

Each cell as a share of that year’s total assets.

Balance Sheet

Assets, liabilities, and equity

28 accounts · 1 year

Total assets $14.3B

Total liabilities $9.2B

Shareholders equity $5.0B

Account	2025	Trend
Assets
Cash and Cash Equivalents	6.1%
Accounts Receivable	7.2%
Inventory	7.5%
Prepaid Expenses	5.1%
Other Current Assets	5.1%
Total Current Assets	27.0%
Property,Plant and Equipment	0.0%
Operating Lease Assets	1.5%
Goodwill	39.9%
Intangible Assets	18.1%
Other Noncurrent Assets	5.7%
Total Assets	100.0%
Liabilities
Accounts Payable	4.8%
Accrued Liabilities	3.0%
Deferred Revenue	4.3%
Current Portion of Long Term Debt	0.0%
Other Current Liabilities	9.7%
Total Current Liabilities	21.9%
Long Term Debt	35.2%
Deferred Tax Liabilities	1.1%
Other Noncurrent Liabilities	3.8%
Total Liabilities	64.7%
Equity
Common Stock	0.0%
Additional Paid In Capital	27.1%
Retained Earnings	12.6%
Accumulated Other Comprehensive Income	-4.4%
Total Stockholders Equity	35.3%
Total Liabilitiesand Equity	100.0%

Income Statement

Revenue, expense, and profitability

16 accounts · 1 year

Revenue $8.3B

Operating income $2.2B

Net income $1.6B

Account	2025	Trend
IncomeStatement
Revenues Total Revenue	58.2%
Expenses Research and Development	5.2%
Expenses Selling,General and Administrative	21.5%
Expenses Depreciation and Amortization	3.4%
Expenses Share Based Compensation	1.1%
Other Income Expense Gross Profit	31.1%
Other Income Expense Operating Income	15.3%
Other Income Expense Other Income/expense	-0.3%
Other Income Expense Income Before Tax	12.0%
Income Tax Income Tax Expense	1.1%
net Income net Income	10.9%
net Income Comprehensive Income	13.9%
Earnings Per Share Basic Eps	0.0%
Earnings Per Share Diluted Eps	0.0%
Earnings Per Share Weighted Average Shares Basic	1.2%
Earnings Per Share Weighted Average Shares Diluted	1.2%

Cash Flow Statement

Operating, investing, and financing flows

20 accounts · 1 year

Operating cash flow $369.0M

Investing cash flow $2.8B

Financing cash flow $-3.1B

Account	2025	Trend
CashFlow
Operating Activities net Income	10.9%
Operating Activities Depreciation and Amortization	3.4%
Operating Activities Stock Based Compensation	1.1%
Operating Activities Deferred Income Taxes	-0.8%
Operating Activities Changes In Operating Assets and Liabilities	1.5%
Operating Activities Other Non Cash Items	-1.4%
Operating Activities net Cash From Operating Activities	2.6%
Investing Activities Capital Expenditures	2.7%
Investing Activities Business Acquisitions	4.9%
Investing Activities Other Investing Activities	0.1%
Investing Activities net Cash From Investing Activities	19.6%
Financing Activities Proceeds From Debt	0.0%
Financing Activities Repayment of Debt	21.5%
Financing Activities Tax Withholding On Stock Based Compensation	0.2%
Financing Activities Other Financing Activities	0.3%
Financing Activities net Cash From Financing Activities	-21.4%
Cash Reconciliation Effect of Exchange Rate On Cash	6.1%
Cash Reconciliation net Change In Cash	0.8%
Cash Reconciliation Cash At Beginning of Period	6.1%
Cash Reconciliation Cash At End of Period	6.1%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 1 year

Ratio	2025
Profitability
Gross margin	—
Operating margin	+26.2%
Net margin	+18.7%
FCF margin	-0.1%
Growth
Revenue CAGR (3y)	+0.8%
Returns
ROE	+30.8%
ROA	+10.9%
ROIC	+21.5%
Liquidity
Current ratio	1.23x
Quick ratio	0.61x
Leverage
D/E	1.83x
Interest coverage	—
Efficiency
Asset turnover	0.58x
Cash conversion cycle	—

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched

Solventum

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Recent price history